ANPHAutoritatea Nationala pentru Persoanele cu Handicap (Romania)
References in periodicals archive ?
As a result of the merger, Mera will acquire rights to Ancile's proprietary drug portfolio, which includes the Investigational New Drug ANPH 101, a promising potential therapy for sleep maintenance disorders.
Based on data from the current ANPH 101 trial to confirm efficacy, we will move quickly to find a major pharmaceutical partner to help fund further development work.